Takeda Pharmaceutical (TAK) Earnings Date, Estimates & Call Transcripts → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free tak Stock Alerts $13.06 -0.17 (-1.28%) (As of 04/25/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 9EstimatedActual EPS (Feb. 1) $0.51 Beat By $0.51 Get Takeda Pharmaceutical Earnings AlertsEnter your email address below to receive the latest news and earnings results for TAK and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueTAK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TAK Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). Takeda Pharmaceutical Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:$1.50 EPSNext Year EPS Consensus Estimate: $1.55 EPSTAK Earnings Date and InformationTakeda Pharmaceutical last posted its quarterly earnings data on February 1st, 2024. The reported $0.51 EPS for the quarter. The firm had revenue of $7.52 billion for the quarter. Takeda Pharmaceutical has generated $0.66 earnings per share over the last year ($0.66 diluted earnings per share) and currently has a price-to-earnings ratio of 19.8. Earnings for Takeda Pharmaceutical are expected to grow by 3.33% in the coming year, from $1.50 to $1.55 per share. Takeda Pharmaceutical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.Read More Takeda Pharmaceutical Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/9/2024Estimated)------- 2/1/2024Q3 2024-$0.51+$0.51$0.79-$7.52 billion10/26/2023Q2 2024-$0.50+$0.50$0.86-$6.94 billion7/27/2023Q1 2024-$0.55+$0.55$0.89-$7.71 billion5/11/2023Q4 2023-$0.39+$0.39$0.70-$7.23 billion2/2/2023Q3 2023-$0.46+$0.46$0.63-$8.40 billion10/27/2022Q2 2023-$0.52+$0.52$0.90-$7.26 billion Get the Latest News and Ratings for TAK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Takeda Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 7/28/2022Q1 2023-$0.56+$0.56$0.86-$7.51 billion5/11/2022Q4 2022-$0.38+$0.38$0.79-$7.19 billion2/3/2022Q3 2022-$0.54+$0.54$0.91-$8.21 billion 10/28/2021Q2 2022-$0.45+$0.45$0.77-$7.67 billion7/30/2021Q1 2022-$0.51+$0.51$0.44-$8.68 billion 5/11/2021Q4 2021-$0.41+$0.41$0.23-$7.27 billion Takeda Pharmaceutical Earnings - Frequently Asked Questions When is Takeda Pharmaceutical's earnings date? Takeda Pharmaceutical has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on TAK's earnings history. How much revenue does Takeda Pharmaceutical generate each year? Takeda Pharmaceutical (NYSE:TAK) has a recorded annual revenue of $29.81 billion. How much profit does Takeda Pharmaceutical generate each year? Takeda Pharmaceutical (NYSE:TAK) has a recorded net income of $2.35 billion. TAK has generated $0.66 earnings per share over the last four quarters. What is Takeda Pharmaceutical's price-to-earnings ratio? Takeda Pharmaceutical (NYSE:TAK) has a trailing price-to-earnings ratio of 19.80 and a forward price-to-earnings ratio of 8.71. The price/earnings-to-growth ratio is 3.02. What is Takeda Pharmaceutical's EPS forecast for next year? Takeda Pharmaceutical's earnings are expected to grow from $1.50 per share to $1.55 per share in the next year, which is a 3.33% increase. More Earnings Resources from MarketBeat Related Companies: Genmab A/S Earnings Results Alnylam Pharmaceuticals Earnings Results BioMarin Pharmaceutical Earnings Results Teva Pharmaceutical Industries Earnings Results Zoetis Earnings Results Viatris Earnings Results BeiGene Earnings Results Karuna Therapeutics Earnings Results Dr. Reddy's Laboratories Earnings Results Sarepta Therapeutics Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NYSE:TAK) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Takeda Pharmaceutical Company Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
